Third-quarter revenue is forecast to rise by 3.0% sequentially to $1.02 billion and fall 13.6% year over year. The company is expected to post EPS of $0.04, up by three cents sequentially and better than a loss of $0.34 per share in the year-ago quarter. For the full fiscal year, analysts expect EPS of $0.11, up from a loss of $1.22 per share last year, on revenue of $4.03 billion, down 16.1%.
The stock trades at 22.9 times expected 2022 EPS, 12.9 times estimated 2023 earnings of $0.22 and 8.7 times estimated 2024 earnings of $0.32 per share. The stock’s 52-week range is $1.65 to $7.22. The company does not pay a dividend, and the total shareholder return for the past year was negative 60.5%.
Medtronic
Medical device maker Medtronic PLC (NYSE: MDT) has posted a share price decline of nearly 32% over the past 12 months. Shares have traded below their 52-week high for a week short of 12 months.
More than 80% of Medtronic’s are held by institutional investors who could make life at least uncomfortable for management unless the company has something to offer besides a decent dividend. The company announced a spin-off of its patient monitoring and respiratory intervention businesses into a separate company in an effort to gin up shareholder value.
Analysts remain upbeat, if not exactly bullish, with 13 of 28 brokerages having a Buy or Strong Buy rating and another 13 rating the shares at Hold. At a price of around $80.40 a share, the upside potential based on a median price target of $102.50 is 27.5%. At the high price target of $127.00, the upside potential is 58%.
Analysts expect the company to report 2023 second-quarter revenue of $7.7 billion, up 4.5% sequentially but down 1.9% year over year. Adjusted EPS are forecast at $1.28, up 13.1% sequentially and by 2.2% year over year. Current estimates for the 2023 fiscal year ending next April call for EPS of $5.53, down about 0.4%, on sales of $31.61 billion, down 0.2%.
Medtronic’s stock trades at 14.6 times expected 2023 EPS, 13.7 times estimated 2024 earnings of $5.87 and 12.8 times estimated 2025 earnings of $6.28 per share. The stock’s 52-week range is $79.19 to $118.80. The company pays an annual dividend of $2.72 (yield of 3.33%). Total shareholder return for the past year was negative 29.7%.
Originally published at 24/7 Wall St.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
